Sectors
Health, Analytics, BioTech
Headquarters
831 Mitten Rd, Burlingame, California, United States
CEO
Othman Laraki
Color Health shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 42.61% discount to their to their last round.Color Health shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 42.61% discount to their to their last round. Color Health shares, as of April 21, 2025, are valued at a price per share implying an approximate +40.65% relative to the most recent significant secondary market activity in July 2023, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Color Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Color Health.
Register today to view the full report, with more in-depth details and analytics
Series E Valuation
Latest funding round
$4.6B
XXXXX
2021-10-21
XX-XX-XXXX
PM Insights Implied Valuation
$2.64B
2025-04-21
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
-42.61%
2021-10-21 ➞ 2025-04-21
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
Color Health shares, as of April 21, 2025, are valued at a price per share implying an approximate +40.65% relative to the most recent significant secondary market activity in July 2023, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Color Health's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Color Health.
Color Health's mutual fund disclosures indicate a three-month moving average fund price per share of $29.19 as of December 30, 2024, according to PM Insights' market data.
PM Insights tracks detailed primary funding rounds and verifies cap table directly from original filings for Color Health. Color Health raised $100.0M in its Series E on October 21, 2021, with a price per share reflecting a post-money valuation of $4.6B, according to PM Insights' market data.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
